| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2008 | WO2007120725A3 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 07/10/2008 | WO2007117558A3 Antioxidants and methods of their use |
| 07/10/2008 | WO2007115821A3 Organic compounds |
| 07/10/2008 | WO2007096764A3 Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
| 07/10/2008 | WO2007096739A3 Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof |
| 07/10/2008 | WO2007076320A8 Compounds |
| 07/10/2008 | WO2007067779A3 Methods and compositions for drug delivery enhancement |
| 07/10/2008 | WO2007064553A3 Thiazole derivatives as cxcr3 receptor modulators |
| 07/10/2008 | WO2007062403A9 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 07/10/2008 | WO2007062335A8 New pleuromutilin derivative and its use |
| 07/10/2008 | WO2006138421A3 Nanoparticulate azelnidipine formulations |
| 07/10/2008 | WO2006053250A3 Lipase inhibitors |
| 07/10/2008 | WO2006052496A8 Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080167630 Controlled delivery system |
| 07/10/2008 | US20080167513 Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions |
| 07/10/2008 | US20080167483 extraction of pharmaceutically active components from plant materials |
| 07/10/2008 | US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators |
| 07/10/2008 | US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
| 07/10/2008 | US20080167466 Capped pyrazinoylguanidine sodium channel blockers |
| 07/10/2008 | US20080167464 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167444 Abc Transporter Inhibitor |
| 07/10/2008 | US20080167437 combining diisocyanates, alcohols-2 and polymerization catalyst comprising a tertiary amine-carboxylic acid salt that is blocked at room temperature and becomes unblocked at an elevated temperature, then heating the mixture to unblock the salt and polymerize the composition to form a polyurethane |
| 07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/10/2008 | US20080167384 Adding to food or beverage; all forms of retinitis pigmentosa, night blindness |
| 07/10/2008 | US20080167382 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 07/10/2008 | US20080167381 5-Amino-4-Hydroxy-2-Isopropyl-7-[4-Methoxy-3-(3-Methoxypropoxy)Benzyl]-8-Methylnonamides |
| 07/10/2008 | US20080167380 Acyl Hydrazines as Kinase Inhibitors, in Particular for Sgk |
| 07/10/2008 | US20080167379 Ointment |
| 07/10/2008 | US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |
| 07/10/2008 | US20080167377 Novel compounds |
| 07/10/2008 | US20080167376 Methods and products which utilize N-acyl-L-aspartic acid |
| 07/10/2008 | US20080167375 Topical administration of a glycerol caprylate formulation also containing a fungicide, corticosteroid, NSAID, vitamin D3 analogue, immunomodulator, antiseptic, viricide, sunscreen agent or an antiacne agent; no need to coadminister other antiinflammatory agents, including nicatinamide derivatives |
| 07/10/2008 | US20080167373 intermediate for side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones); 4-Bromo-5(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone from N-bromosuccinimide the 3-ethylfuranone |
| 07/10/2008 | US20080167372 Schisandrin b preparation |
| 07/10/2008 | US20080167371 Diaryl, Dipyridinyl and Aryl-Pyridinyl Derivatives and Uses Thereof |
| 07/10/2008 | US20080167370 Multidrug multiligand conjugates for targeted drug delivery |
| 07/10/2008 | US20080167369 Semisynthesis Process for the Preparation of 10-Deacytyl-N-Debenzoyl-Paclitaxel |
| 07/10/2008 | US20080167368 4-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-3-carboxamide; anticarcinogenic agents; FAK, KDR and Tie2 kinase inhibitors |
| 07/10/2008 | US20080167367 Stable hydrate of a muscarinic receptor antagonist |
| 07/10/2008 | US20080167366 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167364 Ramipril-amine salts |
| 07/10/2008 | US20080167363 Such as melatonin, GR-135,531, or ramelteon in combination with an antidepressant, an ACE inhibitor, or a 5HT1 agonist; nervous system disorders, neurodegenerative disorders, psychological disorders, transplants |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167361 Piperazinyl-substituted quinolinone compounds ;to treat nervous system diseases, neurodegenerative diseases; gastrointestinal tract disorders; cognition enhancers; 3-[4-(3-Ethylsulfanyl-benzenesulfonyl)-2-methoxy-phenyl]-pyrrolidine and 5-(3-Ethylsulfanyl-benzenesulfonyl)-2-pyrrolidin-3-yl-phenol |
| 07/10/2008 | US20080167360 Cycloalkylidene Compounds as Selective Estrogen Receptor Modulators |
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167358 Methods for Obtaining a Fast Dissolving Imidapril Powder |
| 07/10/2008 | US20080167357 Azabicyclo (3.1.0) Hexane Derivatives Useful as Modulators of Dopamine D3 Receptors |
| 07/10/2008 | US20080167356 metabolic syndrome, diabetes, cholestatic liver disease, fibrosis; improved glucose tolerance and decreased insulin resistance; 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid |
| 07/10/2008 | US20080167355 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/10/2008 | US20080167354 Treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid |
| 07/10/2008 | US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester |
| 07/10/2008 | US20080167352 3-(4-Chloro-phenyl)-adamantane-1-carboxylic acidisopropylamide; antiproliferative, antiinflammatory agent, angiogenesis inhibitor; sphingolipid-derived signaling pathway; coupling acid or acylhalide of phenyl-adamantane derivatives with aminoalkyl-pyridine |
| 07/10/2008 | US20080167351 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
| 07/10/2008 | US20080167349 Pharmaceutical Product For Injection |
| 07/10/2008 | US20080167348 Chymase inhibitors; to treat allergic, inflammatory and fibrotic diseases; 5-Fluoro-3-methyl-benzo[b]thiophene-2-sulfonic acid (4-bromo-2-trifluoromethyl-phenyl)-amide |
| 07/10/2008 | US20080167347 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives |
| 07/10/2008 | US20080167346 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167344 Indoles |
| 07/10/2008 | US20080167343 Methods and compositions using cholinesterase inhibitors |
| 07/10/2008 | US20080167342 Heteroaryl-Substituted Amides Comprising An Unsaturated Or Cyclic Linker Group, And Their Use As Pharmaceuticals |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167340 6-Aminoisoquinoline Compounds |
| 07/10/2008 | US20080167339 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration |
| 07/10/2008 | US20080167338 Compounds and methods for kinase modulation, and indications therefor |
| 07/10/2008 | US20080167337 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
| 07/10/2008 | US20080167336 Azaadamantane derivatives and methods of use |
| 07/10/2008 | US20080167335 To obtain zotarolimus and other rapamycin products |
| 07/10/2008 | US20080167334 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
| 07/10/2008 | US20080167333 e.g. '-(1-Benzothien-2-ylcarbonyl)-3H-spiro[2-benzofuran-1,4'-piperidine; vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/10/2008 | US20080167332 Novel Compounds 243 |
| 07/10/2008 | US20080167331 Lowering intraocular pressure; glaucoma |
| 07/10/2008 | US20080167330 Anticancer agents |
| 07/10/2008 | US20080167329 3,4-Dihydroquinazolin-2(1H)-ones, e.g., 4-Ethyl-6-chloro-4-phenyl-3-(2,2,2-trifluoroethyl)-3,4-dihydroquinazolin-2(1H)-one; treatment of epilepsy, pain, movement disorders, cognitive disorders, psychological disorders, sleep disorders, hot flashes, fibromyalgia, and drug withdrawl |
| 07/10/2008 | US20080167328 Antitumor agents |
| 07/10/2008 | US20080167327 Crystalline, formed by crystallizing from an aqueous solution without agitation; treating cancer |
| 07/10/2008 | US20080167326 Determining the identity of one or more nucleotides at a polymorphic site in a gene encoding fibroblast growth factor-binding protein; and determining the status of the individual by reference the nucleotides; drug secreening; modulating FGF-BP1 expression |
| 07/10/2008 | US20080167325 Preparation of a valacyclovir composition that does not include wet granulation, e.g., dry granulation and compressing a powder blend to form tablets |
| 07/10/2008 | US20080167324 Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives |
| 07/10/2008 | US20080167323 Substituted Triazole Derivatives as Oxytocin Antagonists |
| 07/10/2008 | US20080167322 Substituted Pyrazoles as Modulators of Chemokine Receptors |
| 07/10/2008 | US20080167321 Administering pyridine, pyrimidine or pyridazine derivatives, e.g., N-Hexyl-2-[4-(5-hexylamino-2-trifluoromethylbenzoyl)piperazin-1-yl]isonicotinamide and 5-[4-(5-Fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]-N-pentylnicotinamide, to treat Type II diabetes, obesity, fatty liver, and metabolic syndrome |
| 07/10/2008 | US20080167320 Compounds are selective ligands for the dopamine D3 receptor; psychotic or depressive disorders, dyskinesia, essential tremor; 2-{4-[4-(3-trifluoromethylphenyl)piperazin-1-yl]butyl}amino-4-phenylpyridine; neuropsychiatry; drug dependency/abuse |
| 07/10/2008 | US20080167319 7-(4-(4-[3-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-naphthyridin-2(1h)-one |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167317 Combination Therapy |
| 07/10/2008 | US20080167316 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders |
| 07/10/2008 | US20080167315 Analgesics; potassium channel moderators; headaches; antiepileptic agents; psychological disorders; incontinence; neuropathic pain |
| 07/10/2008 | US20080167314 Condensed Imidazole Compound And Use Thereof |
| 07/10/2008 | US20080167313 Antidiabetic agents; dyslipidemia; hhypoglycemic agents; atherosclerosis ; obesity; antiinflammatory agents; metabolism disorders |
| 07/10/2008 | US20080167312 Preparation and utility of substituted allylamines |
| 07/10/2008 | US20080167311 Glaucome therapy; vision defects |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167309 Pharmaceutical Compounds |
| 07/10/2008 | US20080167308 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |